People's United Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $871K | Sell |
14,651
-2,873
| -16% | -$184K | 0.02% | 344 |
|
|
2021
Q4 | $1.27M | Sell |
17,524
-5,080
| -22% | -$350K | 0.03% | 319 |
|
|
2021
Q3 | $1.58M | Sell |
22,604
-1,283
| -5% | -$90.1K | 0.04% | 290 |
|
|
2021
Q2 | $1.65M | Sell |
23,887
-1,759
| -7% | -$117K | 0.04% | 288 |
|
|
2021
Q1 | $1.66M | Sell |
25,646
-1,380
| -5% | -$89K | 0.04% | 275 |
|
|
2020
Q4 | $1.57M | Sell |
27,026
-15,387
| -36% | -$928K | 0.04% | 263 |
|
|
2020
Q3 | $2.68M | Sell |
42,413
-5,267
| -11% | -$365K | 0.07% | 173 |
|
|
2020
Q2 | $3.67M | Sell |
47,680
-3,250
| -6% | -$249K | 0.11% | 146 |
|
|
2020
Q1 | $3.81M | Buy |
50,930
+890
| +2% | +$61.5K | 0.13% | 137 |
|
|
2019
Q4 | $3.25M | Sell |
50,040
-428
| -0.8% | -$27.9K | 0.09% | 174 |
|
|
2019
Q3 | $3.2M | Sell |
50,468
-10,111
| -17% | -$661K | 0.09% | 180 |
|
|
2019
Q2 | $4.09M | Sell |
60,579
-25,694
| -30% | -$1.69M | 0.11% | 161 |
|
|
2019
Q1 | $5.61M | Sell |
86,273
-12,254
| -12% | -$814K | 0.17% | 111 |
|
|
2018
Q4 | $6.16M | Sell |
98,527
-18,068
| -15% | -$1.26M | 0.21% | 101 |
|
|
2018
Q3 | $9M | Sell |
116,595
-6,048
| -5% | -$457K | 0.28% | 84 |
|
|
2018
Q2 | $8.69M | Sell |
122,643
-17,581
| -13% | -$1.24M | 0.22% | 128 |
|
|
2018
Q1 | $10.6M | Sell |
140,224
-19,140
| -12% | -$1.52M | 0.33% | 75 |
|
|
2017
Q4 | $11.4M | Sell |
159,364
-17,912
| -10% | -$1.36M | 0.36% | 72 |
|
|
2017
Q3 | $14.4M | Sell |
177,276
-26,946
| -13% | -$2.06M | 0.48% | 62 |
|
|
2017
Q2 | $14.5M | Sell |
204,222
-43,341
| -18% | -$2.88M | 0.49% | 57 |
|
|
2017
Q1 | $16.8M | Sell |
247,563
-31,247
| -11% | -$2.2M | 0.59% | 47 |
|
|
2016
Q4 | $20M | Buy |
278,810
+35,991
| +15% | +$2.68M | 0.74% | 33 |
|
|
2016
Q3 | $19.2M | Sell |
242,819
-8,652
| -3% | -$703K | 1.01% | 22 |
|
|
2016
Q2 | $21M | Sell |
251,471
-9,806
| -4% | -$870K | 1.12% | 20 |
|
|
2016
Q1 | $24M | Buy |
261,277
+2,569
| +1% | +$232K | 1.27% | 14 |
|
|
2015
Q4 | $26.2M | Buy |
258,708
+4,894
| +2% | +$509K | 1.39% | 12 |
|
|
2015
Q3 | $24.9M | Sell |
253,814
-1,505
| -0.6% | -$167K | 1.41% | 11 |
|
|
2015
Q2 | $29.9M | Sell |
255,319
-14,841
| -5% | -$1.62M | 1.57% | 8 |
|
|
2015
Q1 | $26.5M | Sell |
270,160
-5,328
| -2% | -$541K | 1.35% | 12 |
|
|
2014
Q4 | $26M | Sell |
275,488
-15,186
| -5% | -$1.57M | 1.32% | 12 |
|
|
2014
Q3 | $30.9M | Sell |
290,674
-15,322
| -5% | -$1.5M | 1.64% | 9 |
|
|
2014
Q2 | $25.4M | Sell |
305,996
-33,877
| -10% | -$2.64M | 1.35% | 15 |
|
|
2014
Q1 | $24.1M | Sell |
339,873
-49,753
| -13% | -$3.9M | 1.44% | 10 |
|
|
2013
Q4 | $29.3M | Sell |
389,626
-31,798
| -8% | -$2.21M | 1.68% | 8 |
|
|
2013
Q3 | $26.5M | Sell |
421,424
-40,208
| -9% | -$2.4M | 1.68% | 7 |
|
|
2013
Q2 | $23.7M | Buy |
+461,632
| New | +$24.1M | 1.54% | 9 |
|
Other funds holding GILD
People's United Financial's GILD Position: Q1 2022 in Review
People's United Financial reduced its Gilead Sciences (GILD) stake by 16% in Q1 2022, selling an estimated $184K and leaving 14,651 shares worth $871K. The position accounts for 0.02% of the portfolio, ranked #344.
People's United Financial first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $30.9M in Q3 2014. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- People's United Financial held 14,651 shares of Gilead Sciences worth $871K as of Q1 2022.
- People's United Financial sold 2,873 Gilead Sciences shares in Q1 2022, an estimated $184K.
- Gilead Sciences made up 0.02% of People's United Financial's portfolio in Q1 2022, its #344 holding.
- People's United Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- People's United Financial's Gilead Sciences position peaked at $30.9M in Q3 2014.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.